GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins
GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins June 18, 2024 GNQ Insilico, Inc. (“GNQ” or “the Company”), a cutting-edge TechBio platform company, demonstrated promising results in synthesizing digital twins human patients, and simulating the effects of an infertility drug on these digital replicas […]
